API
< Back to all clusters
[HEALTH] · Brazil · 2 sources

started · updated

Distrito Federal expands access to long-acting insulin

Basic Health Units (UBSs) in the Distrito Federal have begun offering glargine, a long-acting insulin, to specific priority groups. The medication is available to children and adolescents aged 2 to 17 with type 1 diabetes, as well as individuals aged 70 or older with either type 1 or type 2 diabetes.

This initiative is part of a Ministry of Health strategy to transition from traditional human insulins, such as NPH and regular insulin, to more modern therapeutic alternatives. This shift responds to global supply challenges regarding traditional human insulins. Glargine provides up to 24 hours of action with a single daily dose and is noted for reducing the risk of nocturnal hypoglycemia.

To receive the medication for the first time, eligible patients must visit the UBS corresponding to their residential ZIP code for initial delivery and instructions. Subsequent pickups can be made at any UBS within the Distrito Federal network. Patients already managed by High-Cost Pharmacies should continue to receive their medication through those specific establishments. Other type 2 diabetes patients outside the primary age groups can access the insulin at designated locations, including the Taguatinga and Planaltina polyclinics.

Entities

Distrito Federal · Ministry of Health · Secretaria de Saúde do Distrito Federal